Delivery Order SPE2DB20D3101-SPE2DB25FRWX5
Award Date 9/27/25
Potential Completion Date 9/29/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 8, 2025, for the supply of Insulin Lispro 100 Unit/ML pens (3ML) with a ceiling value of $1,358.28. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025, and is being funded through the Medical Supply Chain, a defense-oriented federal agency. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.14 to AmerisourceBergen Drug Corp for Insulin Lispro 100 Unit/mL pen 3mL on July 24, 2025, with completion scheduled for July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.42 on August 19, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL). This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation. The place of...
- The Defense Logistics Agency awarded a $1,005.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Insulin Lispro 100 Unit/ML vials (10 ml) on September 23, 2025, with a completion date of September 24, 2025. The award was not set-aside and represents a competitively awarded delivery order under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.96 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a firm fixed price structure. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and is not designated as a set-aside contract. This delivery order represents a competitive award exercised under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.24 delivery order contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication for diabetes management. The contract has an ultimate completion date of October 24, 2022 and is a firm fixed-price delivery order. This award is associated with AmerisourceBergen's larger $999,999,999...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $945 to Amerisourcebergen Drug Corporation for the supply of 100 unit/ml pens of insulin lispro in 3ml quantities. As a major division of Amerisourcebergen Corporation, the prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania location to support DLA requirements. No additional details were provided regarding the solicitation, vehicle, or subcontractors involved....
- The Defense Logistics Agency (DLA) awarded a $2,859.79 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens under a firm fixed-price contract type. The award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $2,826.40 delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/ML pens (3ML) on June 17, 2025, with an ultimate completion date of June 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's significant $999,999,999...
- The Defense Logistics Agency awarded a $1,023.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10 mL) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The place of...